Sponsored by the University of Medicine & Dentistry of New Jersey (UMDNJ), UMDNJ-Center for Continuing & Outreach Education. This activity is supported by an educational grant from NJDHSS Division of HIV/AIDS Services through a MOA titled “Education and Training for Physicians and other Healthcare Professionals in the Diagnosis and Treatment of HIV/AIDS.”
This activity is supported by an educational grant from NJDHSS Division of HIV/AIDS Services through a MOA titled “Education and Training for Physicians and other Healthcare Professionals in the Diagnosis and Treatment of HIV/AIDS.”
This activity is designed for physicians and nurses, and for other health care professionals in New Jersey who are involved in the care of persons with HIV/AIDS and others at risk of infection.
Statement of Need
On November 2, 2007, the CDC issued Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States: http://aidsinfo.nih.gov/contentfiles/PerinatalGL.pdf
New legislation takes effect in New Jersey in June 2008 (P.L. 2007 C218) which will have a significant effect both on providers caring for pregnant women and on the women in care. Medical management of pregnant women and pregnant women with HIV infection is rapidly evolving. These legal and medical management issues pose a challenge as clinicians must keep up-to-date. This article will discuss the practical impact of the new law on delivery of care to pregnant women and will highlight recent changes in clinical management.
Upon completion of this learning activity, the reader should be able to:
- Distinguish between routine and opt-out HIV testing protocols.
- Outline the required information to provide to pregnant women before
administering HIV tests under the 2007 New Jersey legislation.
- Explain the increased emphasis on HIV testing in the third-trimester
or at labor and delivery.
- Summarize the interventions with HIV-positive women which can
reduce perinatal transmission, from pre-conceptual counseling through
Method of Instruction
Participants should read the learning objectives and review the activity in its entirety. After reviewing the material, complete the post-test which consists of a series of multiple-choice and True/False questions.
Upon completing this activity as designed and achieving a passing score of 70% or more on the post-test, participants will will have access to a printable online credit statement. Estimated time to complete this activity as designed is 1.25 hours.
EXPIRED- CE is no longer available for this activity. This content is being provided for informational purposes only.
UMDNJ–Center for Continuing and Outreach Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. UMDNJ–Center for Continuing and Outreach Education designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
UMDNJ-Center for Continuing & Outreach Education is an approved provider of continuing nursing education by the New Jersey State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded 1.25 contact hours. (60 minute CH.)
Provider approved by the California Board of Registered Nursing, Provider Number CEP 13780.
UMDNJ-Center for Continuing and Outreach Education certifies that this continuing education offering meets the criteria for up to 0.125 Continuing Education units (CEU's). One CEU equals 10 contact hours of participation.
This activity was peer reviewed for relevance, accuracy of content and balance of presentation by Patricia Kloser, MD, MPH; and Brenda Christian, MEd, PA-C; and pilot tested for relevance and time required for participation by Kinshasa Morton, MD; Bonnie Abedini, RN, MSN; Linda Berezny, RN, BA; and Mary C.Krug, RN, MSN,APN-C.
Carolyn Burr, EdD, RN, is the Senior Education Specialist, François Xavier Bagnoud (FXB) Center, School of Nursing, UMDNJ.
Sindy M. Paul, MD, MPD, FACPM is the Medical Director of the NJ Dept. of Health and Senior Services, Division of HIV/AIDS Services (NJDHSS-DHAS); Assistant Clinical Professor at UMDNJ and past President, New Jersey Board of Medical Examiners.
Linda Dimasi, MPA, is an Analyst I, Research & Evaluation/Health Data Specialist I at the HIV/AIDS Surveillance Unit in NJDHSS-DHAS.
Rebecca Fry, MSN, APN, is the Advanced Practice Nurse for Global Programs, François Xavier Bagnoud (FXB) Center, School of Nursing, UMDNJ.
Patricia C.Kloser, MD, MPH, FACP is Professor of Medicine and Preventive Medicine and Public Health, UMDNJ-New Jersey Medical School and School of Public Health; and Medical Director, Division of AIDS Education, UMDNJ-Center for Continuing & Outreach Education.
Faculty Disclosure Declarations
The following have no financial relationships to disclose:
FACULTY: Carolyn Burr, EdD, RN; Sindy M. Paul, MD, MPH, FACPM; Linda Dimasi, MPA; and Rebecca Fry, MSN, APN
REVIEWERS: Patricia Kloser, MD, MPH; Brenda Christian, MEd, PA-C; Kinshasa Morton, MD.; Bonnie Abedini, BSN, MS; Linda Berezny, RN, BA; and Mary C. Krug, RN, MSN, APN-C; and New Jersey AIDSLine editor Kimi Nakata, MSW, MPH.
Off-Label Usage Disclosure
This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
The views expressed in this activity are those of the faculty.It should not be inferred or assumed that they are expressing the views of NJDHSS-Division of HIV/AIDS Services, UMDNJ, or any manufacturer of pharmaceuticals.The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult the full prescribing information on any agent(s) presented in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication. This is particularly important when a drug is new or infrequently prescribed.
Copyright© 2008 UMDNJ-Center for Continuing & Outreach Education. All rights reserved including translation into other languages.No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission inwriting from UMDNJ-Center for Continuing & Outreach Education.